US4483846A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Long-lasting three-layered pharmaceutical film preparations
Assignee: Ono Pharmaceutical Co Ltd
•
Filing: 1983-02-07
•
Granted: 1984-11-20
•
Expires: 2003-02-07
Abstract
Abstract The present invention provides new three-layered pharmaceutical film preparations which comprise one drug-storing middle layer composed of one or more (a) polyvinylpyrrolidone, (b) hydroxypropyl cellulose, (c) plasticizers and (d) organic acids, containing prostaglandin analogues, and two release-controlling layers on both sides of the said middle layer, composed of one or more (a) hydroxypropyl cellulose and (b) plasticizers, containing or not containing prostaglandin analogues, and which may release the drug at the desired concentration lastingly for an extended period of time, with great high biological availability, and can make this release "zero-order release", and further have improved the stability of the drug contained therein, and in which the form of the preparation is not retained at the administered site after administration.
Inventors
- 👤 Tatsushi Koide
- 👤 Seiei Sasatani
- 👤 Kohji Inaba
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:49
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/70; A61K9/7023; A61K9/703; A61K9/7038; A61K9/7046; A61K9/7053; A61K9/7092
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
67 words
A three-layered pharmaceutical film preparation which comprises one drug-storing middle layer comprising at least one of each of (a) polyvinylprrolidone, (b) hydroxypropyl cellulose, (c) plasticizer, (d) organic acid and (e) prostaglandin analogue, and two release-controlling layers, one on each side of said middle layer, comprising at least one of each of (a) hydroxypropyl cellulose and (b) plasticizer, additionally containing or not containing at least one prostaglandin analogue.
Claim 2
Dependent Claim
67 words
A three-layered pharmaceutical film preparation which comprises one drug-storing middle layer comprising at least one of each of (a) polyvinylprrolidone, (b) hydroxypropyl cellulose, (c) plasticizer, (d) organic acid and (e) prostaglandin analogue, and two release-controlling layers, one on each side of said middle layer, comprising at least one of each of (a) hydroxypropyl cellulose and (b) plasticizer, additionally containing or not containing at least one prostaglandin analogue.
Claim 3
Dependent Claim
18 words
A three-layered pharmaceutical film preparation according to claim 1, wherein the release-controlling layers do not contain prostaglandin analogues.
Claim 4
Dependent Claim
16 words
A three-layered pharmaceutical film preparation according to claim 1, wherein the release-controlling layers contain prostaglandin analogues.
Claim 5
Dependent Claim
19 words
A three-layered pharmaceutical film preparation according to claim 2 or 3, wherein the molecular weight of polyvinylpyrrolidone is 300,000-400,000.
Claim 6
Dependent Claim
20 words
A three-layered pharmaceutical film preparation according to claim 2 or 3, wherein the molecular weight of hydroxypropyl cellulose is 250,000-400,000.
Claim 7
Dependent Claim
23 words
A three-layered pharmaceutical film preparation according to claim 2 or 3, wherein the plasticizer is propylene glycol, glycerol, polyethylene glycol or lauryl alcohol.
Claim 8
Dependent Claim
21 words
A three-layered pharmaceutical film preparation according to claim 2 or 3, wherein the organic acid is citric acid or tartaric acid.
Claim 9
Dependent Claim
25 words
A three-layered pharmaceutical film preparation according to claim 2 or 3, wherein the prostaglandin analogue is a prostaglandin F compound or a prostaglandin E compound.
Claim 10
Dependent Claim
68 words
A three-layered pharmaceutical film preparation according to claim 2, wherein the drug-storing middle layer is composed of (a) polyvinylpyrrolidone having the molecular weight of 300,000-400,000, (b) hydroxypropyl cellulose having the molecular weight of 250,000-400,000, (c) polyethylene glycol, (d) citric acid and (e) 16,16-dimethyl-trans-Δ 2 -PGE 1 methyl ester, and the release-controlling layers are composed of (a) hydroxypropyl cellulose having the molecular weight of 250,000-400,000 and (b) propylene glycol.
Claim 11
Dependent Claim
67 words
A three-layered pharmaceutical film preparation according to claim 2, wherein the drug-storing middle layer is composed of (a) polyvinylpyrrolidone having the molecular weight of 300,000-400,000, (b) hydroxypropyl cellulose having the molecular weight of 250,000-400,000, (c) lauryl alcohol, (d) tartaric acid and (e) 16,16-dimethyl-trans-Δ 2 -PGE 1 methyl ester, and the release-controlling layers are composed of (a) hydroxypropyl cellulose having the molecular weight of 250,000-400,000 and (b) glycerol.
References Cited (Backward Citations)
US3926188A
Cited
US4180558A
Cited
US4317447A
Cited
US4359483A
Cited
US4335097A
Cited
US4451260A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-11-20 | 1988-05-21 | 1988-11-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-11-20 | 1992-05-21 | 1992-11-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-11-20 | 1996-05-21 | 1996-11-20 | $7700.00 | Window Closed / Lapsed |